|Articles|August 1, 2003
Supplements and Featured Publications
- Examining the Dyslipidemia Constellation
- Volume 9
- Issue 1 Dyslipid
IVUS is redefining atherosclerotic disease
Author(s)Steven E. Nissen, MD
Advertisement
Articles in this issue
over 22 years ago
NCEP ATP III guidelines incorporate global risk assessmentover 22 years ago
Case reports illustrate consequences of ATP III in practiceover 22 years ago
Inflammatory markers are useful risk assessment toolsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
AI-Supported Mammography Caught More Cancers During Screening
2
Combination Therapy, Biologics, and Surgery Redefine HS Care in 2026
3
The Strategic Necessity of Pharma-MedTech Convergence in an Era of Precision Medicine
4
CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment
5
